Corpus Intelligence IC Memo — LOGAN MEMORIAL HOSPITAL 2026-04-26 19:00 UTC
IC Memo — LOGAN MEMORIAL HOSPITAL
Investment Committee Memorandum | KY | 37 beds | Grade D | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LOGAN MEMORIAL HOSPITAL

CCN 180066 | LOGAN, KY | 37 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

LOGAN MEMORIAL HOSPITAL is a 37-bed rural/critical access in LOGAN, KY with $22.1M in net patient revenue and a 0.2% operating margin. The hospital serves a payer mix of 45.2% Medicare, 1.4% Medicaid, and 53.4% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.2% to 7.5% (+736bps).

Net Revenue HCRIS$22.1M
Current EBITDA COMPUTED$36K
Operating Margin COMPUTED0.2%
Occupancy HCRIS12.9%
Revenue / Bed COMPUTED$597K
Net-to-Gross HCRIS15.6%
Distress Probability ML55.9%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
62
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 0.2% places it above the state median. Among 62 size-comparable peers (18-74 beds), the median margin is -1.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-74), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LOGAN MEMORIAL HOSPITAL (Target)KY37$22.1M0.2%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
CLARK REGIONAL MEDICAL CENTERKY54$156.4M16.5%
BAPTIST HEALTH RICHMONDKY53$145.6M-3.7%
HIGHLANDS REGIONAL MEDICAL CENKY63$96.5M-32.6%
FLAGET MEMORIAL HOSPITALKY40$86.2M-0.6%
ROCKCASTLE HOSPT. & RESPIR CARKY30$79.1M2.2%
ADVENTHEALTH MANCHESTERKY49$73.0M-11.0%
HARLAN ARHKY56$69.9M-24.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$464K+210bp18mo
Cost to Collect4.5%2.5%$442K+200bp12mo
Denial Rate Reduction12.0%6.5%$437K+198bp12mo
A/R Days Reduction5200.0%3800.0%$269K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$464K
Cost to Collect
$442K
Denial Rate Reduction
$437K
A/R Days Reduction
$269K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$36K
+ RCM Uplift+$1.6M
Pro Forma EBITDA$1.7M
Current Margin0.2%
Pro Forma Margin7.5%
WC Released (1x)$847K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$55K$16.5M300.94x213.1%
Base (11x exit)10.0x11.0x$55K$18.2M331.35x219.2%
Bull Case9.0x11.0x$49K$23.5M477.30x243.4%
Bull (12x exit)9.0x12.0x$49K$25.7M520.99x249.4%
Bear Case11.0x10.0x$60K$8.3M138.44x168.1%
Bear (11x exit)11.0x11.0x$60K$9.2M152.61x173.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 12.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 18-74 beds
  • Same-state prioritization (n=63)
  • Comp margins: P25=-11.1% / P50=-1.6% / P75=9.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.